These researchers demonstrated that this mAb suppressed tumor outgrowth, reduced distant organ tumor cell metastasis, and had enhancing effects on anti-VEGF treatment in MDA-MB-231-established breast cancer xenograft models (153). Here, VEGFA is linked to neoplasm.